← back to search

Hongdian Zhang

Chinese PLA General Hospital · CN
Area of research
Surgery · Pulmonary and Respiratory Medicine
Research interest
Research focused on Angiogenesis and Protein kinase B, with related work in Esophageal cancer, China, PI3K/AKT/mTOR pathway. Notable publications include 'Downregulation of BIRC5 inhibits the migration and invasion of esophageal cancer cells by interacting with the PI3K/Akt signaling pathway', 'Society for Translational Medicine Expert Consensus on the prevention and treatment of postoperative pulmonary infection in esophageal cancer patients', and 'CACA guidelines for holistic integrative management of esophageal carcinoma'.
h-index
citations
69
works
3
NIH funding
primary concept
email

Recent publications

CACA guidelines for holistic integrative management of esophageal carcinoma
Holistic Integrative Oncology 2023cited by 12position: middledoi
Downregulation of BIRC5 inhibits the migration and invasion of esophageal cancer cells by interacting with the PI3K/Akt signaling pathway
Oncology Letters 2018cited by 43position: middledoi
Society for Translational Medicine Expert Consensus on the prevention and treatment of postoperative pulmonary infection in esophageal cancer patients
Journal of Thoracic Disease 2018cited by 14position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Guoyan Liu · Shandong University of Traditional Chinese Medicine1 papers (2018–2018) · 1 papers (2018–2018)Hongjing Jiang · Sun Yat-sen University Cancer Center1 papers (2018–2018)Peng Tang · Army Medical University1 papers (2018–2018)Yue‐Feng Zhang · Wenzhou Medical University1 papers (2018–2018)Zhentao Yu · Sun Yat-sen University Cancer Center1 papers (2018–2018)